Zu-Yi Yuan
Overview
Explore the profile of Zu-Yi Yuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Qi H, Jia H, Wang D, Sun Y, Zhang B, et al.
JACC Asia
. 2025 Jan;
5(1):101-112.
PMID: 39886204
Background: Elevated blood pressure (BP) in childhood is associated with adult hypertension and arterial stiffness. However, the effect of long-term time in target range (TTR) for BP since childhood on...
2.
Wang C, Xing Y, Zhang J, He M, Dong J, Chen S, et al.
Circ Res
. 2022 Oct;
131(10):828-841.
PMID: 36252121
Background: Dysregulated BMP (bone morphogenetic protein) or TGF-β (transforming growth factor beta) signaling pathways are imperative in idiopathic and familial pulmonary arterial hypertension (PAH) as well as experimental pulmonary hypertension...
3.
Wang C, Wu H, Xing Y, Ye Y, He F, Yin Q, et al.
Sci Rep
. 2022 Jan;
12(1):344.
PMID: 35013491
Endothelial dysfunction and vascular smooth muscle cell (VSMC) plasticity are critically involved in the pathogenesis of hypertension and arterial stiffness. MicroRNAs can mediate the cellular communication between vascular endothelial cells...
4.
Lei Y, Zhang J, Schiavon C, He M, Chen L, Shen H, et al.
Circ Res
. 2021 Mar;
128(9):1323-1326.
PMID: 33784827
No abstract available.
5.
Lei Y, Zhang J, Schiavon C, He M, Chen L, Shen H, et al.
bioRxiv
. 2020 Dec;
PMID: 33300001
Coronavirus disease 2019 (COVID-19) includes the cardiovascular complications in addition to respiratory disease. SARS-CoV-2 infection impairs endothelial function and induces vascular inflammation, leading to endotheliitis. SARS-CoV-2 infection relies on the...
6.
Dong J, He M, Li J, Pessentheiner A, Wang C, Zhang J, et al.
JCI Insight
. 2020 Oct;
5(23).
PMID: 33119548
Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects cholesterol homeostasis by targeting hepatic LDL receptor (LDLR) for lysosomal degradation. Clinically, PCSK9 inhibitors effectively reduce LDL-cholesterol (LDL-C) levels and the incidence of...
7.
Lu Q, Liu P, Huo J, Wang Y, Ma A, Yuan Z, et al.
BMC Cardiovasc Disord
. 2020 Oct;
20(1):441.
PMID: 33032539
An amendment to this paper has been published and can be accessed via the original article.
8.
Wang Y, Du M, Gao W, Fu B, Yan Y, Yuan Y, et al.
Eur J Clin Nutr
. 2020 Sep;
75(3):531-538.
PMID: 32994554
Background/objectives: Chronic kidney disease (CKD) is a global public health problem, including in China. The aim of this study was to identify the risk factors for the development and progression...
9.
Lu Q, Liu P, Huo J, Wang Y, Ma A, Yuan Z, et al.
BMC Cardiovasc Disord
. 2020 Sep;
20(1):409.
PMID: 32912149
Background: Cardiac rupture (CR) is a fatal complication of ST-elevation myocardial infarction (STEMI) with its incidence markedly declined in the recent decades. However, clinical features of CR patients now and...
10.
Shen H, Zhang J, Wang C, Jain P, Xiong M, Shi X, et al.
Circulation
. 2020 Aug;
142(12):1190-1204.
PMID: 32755395
Background: Angiotensin-converting enzyme 2 (ACE2) converts angiotensin II, a potent vasoconstrictor, to angiotensin-(1-7) and is also a membrane protein that enables coronavirus disease 2019 (COVID-19) infectivity. AMP-activated protein kinase (AMPK)...